EverydayHealthLogo
HV

Dr. Hannah Valantine, MD

Stanford, CA

41 Years of Experience

Accepting patients

    Who is Dr. Valantine, Cardiologist in Stanford, CA?

    Dr. Hannah Valantine, MD is a Cardiologist, who primarily practices in Stanford, CA with 1 additional practice location. She has been practicing for over 41 years and is board certified. Dr. Valantine graduated from St. George's University of London. Dr. Valantine is fluent in English and French, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Valantine’s office at (650) 497-8000.

    Where did Dr. Valantine go to medical school and complete their residency?

    • Medical School: University College, University of London,London, United Kingdom | St. George's University of London

    What languages does Dr. Valantine speak?

    Dr. Valantine and their clinical team can communicate with patients in the following languages:

    • English

    • French

    What conditions does Dr. Valantine treat?

    As a Cardiologist, Dr. Valantine diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Valantine. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

    Also known as:

    • Having a Heart Transplant
    • Heart Transplantation
    • Cardiac transplant
    • Heart replacement surgery
    • Post-heart transplant

    ICD-10 Codes:

    • Z941: Heart transplant status

    Which procedures does Dr. Valantine perform as a Cardiologist?

    As a Cardiologist, procedures performed by a Dr. Hannah Valantine may include:

    For detailed information, please contact Dr. Valantine's office.

    Does Dr. Valantine accept my insurance?

    Please contact Dr. Valantine's office to confirm accepted insurance plans.

    Where is Dr. Valantine's office located?

    Dr. Hannah Valantine's Primary Practice

    300 Pasteur Dr

    Stanford, CA 94305

    (650) 497-8000

    Get Directions

    Dr. Hannah Valantine's Practice 2

    911 Sunset Dr

    Hollister, CA 95023

    Get Directions

    Recognitions

    Publications

    Transdiscipliry translatiol science and the case of preterm birth

    JOURL OF PERITOLOGY, 2013

    Proliferation sigl inhibitors and post-transplant maligncies in heart transplantation

    CLINICAL TRANSPLANTATION, 2011

    Decisions, Decisions: How Program Diversity Influences Residency Program Choice

    JOURL OF THE AMERICAN COLLEGE OF SURGEONS, 2011

    Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy

    TRANSPLANTATION, 2011

    Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptiol Profiling

    CIRCULATION, 2011

    Universal noninvasive detection of solid organ transplant rejection

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2011

    Academic Couples: Implications for Medical School Faculty Recruitment and Retention

    JOURL OF THE AMERICAN COLLEGE OF SURGEONS, 2011

    Differentially Expressed R from Public Microarray Data Identifies Serum Protein Biomarkers

    PLOS COMPUTATIOL BIOLOGY, 2010

    Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation

    NEW ENGLAND JOURL OF MEDICINE, 2010

    Changing trends in infectious disease in heart transplantation

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2010

    Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodymically Compromising Rejection

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2009

    New developments in immunosuppressive therapy for heart transplantation

    EXPERT OPINION ON EMERGING DRUGS, 2009

    Twenty-year survivors of heart transplantation at Stanford University

    AMERICAN JOURL OF TRANSPLANTATION, 2008

    Effect of rapamycin therapy on corory artery physiology early after cardiac transplantation

    AMERICAN HEART JOURL, 2008

    Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: Modulation by sirolimus

    TRANSPLANTATION, 2008

    Determints of lumen loss between years 1 and 2 after cardiac transplantation

    TRANSPLANTATION, 2007

    Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness

    AMERICAN JOURL OF TRANSPLANTATION, 2007

    Molecular testing for long-term rejection surveillance in heart transplant recipients

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2007

    Cytomegalovirus-associated allograft rejection in heart transplant patients

    CURRENT OPINION IN INFECTIOUS DISEASES, 2007

    Is there a role for proliferation sigl

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2007

    Frequent occult infection with cytomegalovirus

    JOURL OF CLINICAL MICROBIOLOGY, 2007

    Changes in corory atomy and physiology after heart transplantation

    AMERICAN JOURL OF CARDIOLOGY, 2007

    Interplay between systemic inflammation

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2007

    Changes in corory arterial dimensions early after cardiac transplantation

    TRANSPLANTATION, 2007

    Pulmory nocardiosis in a heart transplant patient: Case report and review of the literature

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2007

    Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients

    TRANSPLANTATION, 2006

    Giant corory aneurysms in heart transplantation

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2006

    T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease

    CIRCULATION, 2006

    Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical

    TRANSPLANTATION, 2006

    Discordant changes in epicardial and microvascular corory physiology after cardiac transplantation

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2006

    Wound healing complications with de novo sirolimus versus mycophenolate mofetil

    AMERICAN JOURL OF TRANSPLANTATION, 2006

    Validation of a screening protocol for identifying low-risk c

    CLINICAL TRANSPLANTATION, 2006

    Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2006

    Use of the implantable cardioverter-defibrillator in long

    HEART RHYTHM, 2005

    Induction therapy for pediatric and adult heart transplantation

    TRANSPLANTATION, 2005

    From clinical trials to clinical practice

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2005

    Certican (Everolimus) in heart transplantation

    2005

    Prevention of cardiac allograft vasculopathy with Certican((R)) (everolimus)

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2005

    Cardiac allograft vasculopathy after heart transplantation: Risk factors and magement

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2004

    Glucose intolerance, as reflected by hemoglobin A(1c) level

    JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004

    Cytomegalovirus infection impairs the nitric oxide synthase pathway

    CIRCULATION, 2004

    The role of viruses in cardiac allograft vasculopathy

    AMERICAN JOURL OF TRANSPLANTATION, 2004

    Alysis of survivors more than 10 years after heart transplantation in the cyclosporine era

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2004

    Longer-term risks associated with 10

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2003

    Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant atheroma

    TRANSPLANTATION, 2003

    Post-operative conversion from cyclosporine to tacrolimus in heart transplantation

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2003

    Preferential involvement of larger vessels in a rat model of diabetes induced graft vasculopathy

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2002

    Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection

    TRANSPLANTATION PROCEEDINGS, 2002

    Mycophenolic acid concentrations in long-term heart transplant patients

    CLINICAL TRANSPLANTATION, 2002

    Reversal of diabetes-induced rat graft transplant corory artery disease by metformin

    JOURL OF HEART AND LUNG TRANSPLANTATION, 2002

    Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein

    Blankenberg, F. G., Wen, P. Z., Dai, M., Zhu, D. N., Panchal, S. N., T, 2001

    Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation

    TRANSPLANTATION, 2001

    Transplant corory artery disease - A novel model independent of cellular alloimmune response

    CIRCULATION, 2001

    Detection and treatment of corory artery disease in liver transplant candidates

    LIVER TRANSPLANTATION, 2001

    Mild hyperhomocysteinemia is not associated with cardiac allograft corory disease

    CLINICAL TRANSPLANTATION, 2001

    Severe tricuspid regurgitation after heart transplantation

    Chan, M. C., Giannetti, N., Kato, T., Kornbluth, M., Oyer, P., Valanti, 2001

    Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of

    CIRCULATION, 2001

    Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD

    The Jourl of heart and lung transplantation : the official publication, 2001

    Neoral use in the cardiac transplant recipient

    Valantine, H., 2000

    Impact of prophylactic immediate posttransplant ganciclovir on development of transplant

    CIRCULATION, 1999

    Role of CMV in transplant corory artery disease and survival after heart transplantation.

    Transplant infectious disease, 1999

    Diabetes and dyslipidemia - A new model for transplant corory artery disease

    CIRCULATION, 1998

    Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient

    JOURL OF HEART AND LUNG TRANSPLANTATION, 1998

    Importance of decreased heart rate in predicting transplant corory artery disease

    CLINICAL TRANSPLANTATION, 1997

    Individualizing immunosuppression for heart transplantation: Strategies for the next decade

    TRANSPLANTATION PROCEEDINGS, 1997

    Heart transplantation in patients over 54 years of age - Mortality, morbidity and quality of life

    Rickenbacher, P. R., Lewis, N. P., Valantine, H. A., Luikart, H., Stin, 1997

    Methotrexate or total lymphoid radiation

    JOURL OF HEART AND LUNG TRANSPLANTATION, 1997

    Significant reduction in the number of fungal infections after lung-, heart-lung

    Reichenspurner, H., Gamberg, P., Nitschke, M., Valantine, H., Hunt, S., 1997

    Volume-mediated pulmory responses in liver transplant candidates

    CLINICAL TRANSPLANTATION, 1996

    Early Doppler echocardiographic dysfunction is associated with an increased mortality after

    Circulation, 1996

    Induction of nitric oxide synthase

    CIRCULATION, 1996

    Corory artery intimal thickening in the transplanted heart

    TRANSPLANTATION, 1996

    Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart

    Wagner, J. A., Ross, H., Hunt, S., Gamberg, P., Valantine, H., Merigan, 1995

    The relationship of granzyme A and perforin expression to cardiac allograft rejection

    Alpert, S., Lewis, N. P., Ross, H., Fowler, M., Valantine, H. A., 1995

    PROGNOSTIC IMPORTANCE OF INTIMAL THICKNESS AS MEASURED BY INTRACORORY ULTRASOUND AFTER CARDIAC

    CIRCULATION, 1995

    Incidence and progression of transplant corory artery disease over 1 year

    Yeung, A. C., Davis, S. F., Hauptman, P. J., Kobashigawa, J. A., Mille, 1995

    Role of lipids in allograft vascular disease

    Valantine, H. A., 1995

    MAGNETIC-RESONCE IMAGING

    Kuo, P. C., Alfrey, E. J., Li, K., Vagelos, R., Valantine, H., Garcia,, 1995

    PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS DISEASE IN THORACIC ORGAN TRANSPLANT PATIENTS

    Valantine, H. A., 1995

    CORRELATION OF DONOR CHARACTERISTICS WITH TRANSPLANT CORORY

    AMERICAN JOURL OF CARDIOLOGY, 1995

    CLINICAL OUTCOME OF INTERVAL CADAVERIC REL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS

    CLINICAL TRANSPLANTATION, 1995

    CARDIAC ALLOGRAFT VASCULAR-DISEASE

    CIRCULATION, 1995

    Distribution and morphologic features of corory artery disease in cardiac allografts

    Jourl of the American Society of Echocardiography, 1995

    INCIDENCE AND SEVERITY OF TRANSPLANT CORORY

    JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995

    FEASIBILITY OF SERIAL INTRACORORY ULTRASOUND IMAGING FOR ASSESSMENT OF PROGRESSION OF INTIMAL

    CIRCULATION, 1994

    IMPACT OF CYCLOSPORINE DOSE ON LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION

    Valantine, H., Hunt, S., Gamberg, P., Miller, J., Luikart, H., 1994

    CYTOKINES AS POTENTIAL MEDIATORS OF ACUTE ALLOGRAFT DIASTOLIC DYSFUNCTION IN CYCLOSPORINE

    Valantine, H., Johnson, F., Dong, C., Lewis, N., Tovey, D., Huie, P., , 1994

    Cytokine gene expression in human cardiac allograft recipients.

    Transplant immunology, 1994

    CARDIAC TRANSPLANTATION - THE STANFORD EXPERIENCE IN THE CYCLOSPORINE ERA

    JOURL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994

    EXERCISE ECHOCARDIOGRAPHY IN HEAT TRANSPLANT RECIPIENTS

    JOURL OF HEART AND LUNG TRANSPLANTATION, 1994

    METABOLIC RISK-FACTORS FOR ATHEROSCLEROSIS IN HEART-TRANSPLANT RECIPIENTS

    AMERICAN HEART JOURL, 1994

    RECOVERY OF THE RIGHT VENTRICLE AFTER SINGLE-LUNG TRANSPLANTATION IN PULMORY-HYPERTENSION

    AMERICAN JOURL OF CARDIOLOGY, 1994

    INFLUENCE OF GRAFT-REJECTION ON INCIDENCE OF ACCELERATED GRAFT CORORY

    JOURL OF HEART AND LUNG TRANSPLANTATION, 1993

    INTRACORORY ULTRASOUND IMAGING IN HEART-TRANSPLANT RECIPIENTS - THE STANFORD EXPERIENCE

    Valantine, H., Pinto, F. J., STGOAR, F. G., Alderman, E. L., Popp, R. , 1992

    INTRACORORY ULTRASOUND IN CARDIAC TRANSPLANT RECIPIENTS

    CIRCULATION, 1992

    COST CONTAINMENT - COADMINISTRATION OF DILTIAZEM WITH CYCLOSPORINE AFTER HEART-TRANSPLANTATION

    JOURL OF HEART AND LUNG TRANSPLANTATION, 1992

    NITROGLYCERIN-INDUCED CORORY VASODILATION IN CARDIAC TRANSPLANT RECIPIENTS

    CIRCULATION, 1992

    SENSITIVITY AND SPECIFICITY OF DIASTOLIC INDEXES FOR REJECTION SURVEILLANCE

    Valantine, H. A., YEOH, T. K., Gibbons, R., McCarthy, P., Stinson, E. , 1991

    FREQUENCY AND MECHANISM OF BRADYCARDIA IN CARDIAC TRANSPLANT RECIPIENTS AND NEED FOR PACEMAKERS

    AMERICAN JOURL OF CARDIOLOGY, 1991

    CHANGES IN CARDIAC MORPHOLOGY AND FUNCTION FOLLOWING SINGLE-LUNG TRANSPLANTATION

    TRANSPLANTATION PROCEEDINGS, 1991

    LEFT-VENTRICULAR DIASTOLIC FUNCTION

    CIRCULATION, 1990

    Variability of Doppler echocardiographic indexes of left ventricular filling

    Jourl of the American Society of Echocardiography, 1990

    SERIAL MEASUREMENT OF INTEGRATED ULTRASONIC BACKSCATTER IN HUMAN CARDIAC ALLOGRAFTS FOR THE

    CIRCULATION, 1990

    CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING NEOPLASTIC DISEASES

    AMERICAN JOURL OF CARDIOLOGY, 1990

    Long-term magement and results in heart transplant recipients.

    Cardiology clinics, 1990

    Prevalence of accelerated corory artery disease

    Circulation, 1989

    RECURRENCE OF AMYLOID IN A CARDIAC ALLOGRAFT 4 MONTHS AFTER TRANSPLANTATION

    JOURL OF HEART TRANSPLANTATION, 1989

    FREQUENCY OF FAMILIAL TURE OF DILATED CARDIOMYOPATHY AND USEFULNESS OF CARDIAC TRANSPLANTATION IN

    AMERICAN JOURL OF CARDIOLOGY, 1989

    INCREASING PERICARDIAL-EFFUSION IN CARDIAC TRANSPLANT RECIPIENTS

    CIRCULATION, 1989

    INCREASED BETA-RECEPTOR DENSITY AND IMPROVED HEMODYMIC

    CIRCULATION, 1989

    A HEMODYMIC AND DOPPLER ECHOCARDIOGRAPHIC STUDY OF VENTRICULAR-FUNCTION IN LONG

    CIRCULATION, 1989

    CARDIAC TRANSPLANTATION

    INTENSIVE CARE MEDICINE, 1989

    Changes in Doppler echocardiographic indexes of left ventricular function

    Circulation, 1987

    Cardiac sarcoidosis: response to steroids and transplantation.

    jourl of heart transplantation, 1987

    What is Dr. Valantine's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Valantine's National Provider Identifier (NPI) number is 1063548212.

    What common questions do patients ask about Dr. Valantine?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Valantine

    What is Dr. Hannah Valantine's specialty?

    Dr. Valantine is a Cardiologist near Stanford, CA. An internist specializing in cardiovascular diseases focuses on the diagnosis and management of complex heart and blood vessel conditions, including heart attacks and life-threatening arrhythmias. Contact Dr. Valantine to book an appointment today.

    Is this Dr. Hannah Valantine affiliated with a ranked Castle Connolly Top Hospital?

    No, Valantine is not affiliated with a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Cardiologist?

    Explore Cardiologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Hannah Valantine accepting new patients in Stanford, CA?

    Yes, Dr. Hannah Valantine is accepting new patients at this time.

    Does Dr. Hannah Valantine offer online booking?

    Please contact Dr. Valantine's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Hannah Valantine?

    Please contact Dr. Valantine's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.

    Other Cardiologist Near Stanford, CA

    RS
    acceptingPatients-iconAccepting patients
    Stanford, CA
    CW

    Cardiologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    JT

    Cardiologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists